Peptides DB
Research-centric peptide and protocol reference hub

ARA 290 vs SLU-PP-332 (Exercise Mimetic)

Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team

ARA 290: Research use — not FDA-approvedSLU-PP-332 (Exercise Mimetic): Research use — not FDA-approved

A data-driven comparison of ARA 290 and SLU-PP-332 (Exercise Mimetic) (also searched as SLU-PP-332 (Exercise Mimetic) vs ARA 290) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

ARA 290 centers on neuro, while SLU-PP-332 (Exercise Mimetic) leans toward metabolic. On indexed research, SLU-PP-332 (Exercise Mimetic) is ahead (ARA 290: 33 studies, Human evidence; SLU-PP-332 (Exercise Mimetic): 34, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • ARA 290 is strongest for neuro; SLU-PP-332 (Exercise Mimetic) for metabolic.
  • Evidence: ARA 290 Human evidence (33 studies) vs SLU-PP-332 (Exercise Mimetic) Human clinical (34).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

ARA 290SLU-PP-332 (Exercise Mimetic)

At a glance

ARA 290Human evidence

Neuroprotection | Nerve regeneration

Strongest: NeuroStudies: 33Level: Preclinical

ERR Agonist | Metabolic Modulator

Strongest: MetabolicStudies: 34Level: Emerging

ARA 290 vs SLU-PP-332 (Exercise Mimetic): side-by-side

MetricARA 290SLU-PP-332 (Exercise Mimetic)
ClassNeuroMetabolic
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman clinical
Studies indexed3334
Research levelPreclinicalEmerging
Strongest effectNeuro & moodMetabolic & appetite
Healing & recovery4.01.0
Muscle & body comp0.04.0
Metabolic & appetite2.05.0
Neuro & mood5.02.0
Sleep & circadian0.01.0
Inflammation & immune3.02.0
Skin & aesthetics0.00.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyARA 290SLU-PP-332 (Exercise Mimetic)
MechanismModulates macrophage activity and promotes anti-inflammatory cytokine releasePan-ERR agonist
RouteSubcutaneous injection

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is ARA 290?

ARA 290, also known as a peptide derived from the erythropoietin (EPO) molecule, has garnered attention for its potential therapeutic applications, particularly in the context of nerve regeneration and protection. The peptide is designed to mimic some of the beneficial effects of EPO without eliciting the same erythropoietic activity, which can lead to unwanted side effects such as increased blood viscosity and hypertension.

Full ARA 290 profile, mechanism & studies →

What is SLU-PP-332 (Exercise Mimetic)?

Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator

Full SLU-PP-332 (Exercise Mimetic) profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingARA 2904.0/5 effect signal
MuscleSLU-PP-332 (Exercise Mimetic)4.0/5 effect signal
MetabolicSLU-PP-332 (Exercise Mimetic)5.0/5 effect signal
NeuroARA 2905.0/5 effect signal
SleepSLU-PP-332 (Exercise Mimetic)1.0/5 effect signal
InflammationARA 2903.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack ARA 290 and SLU-PP-332 (Exercise Mimetic)?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

ARA 290 vs SLU-PP-332 (Exercise Mimetic): side effects

ARA 290

No community-reported effects logged yet.

SLU-PP-332 (Exercise Mimetic)

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

ARA 290 has 33 approved studies indexed (Human evidence), and SLU-PP-332 (Exercise Mimetic) has 34 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is ARA 290 or SLU-PP-332 (Exercise Mimetic) better?

It depends on your goal. ARA 290 is strongest for neuro; SLU-PP-332 (Exercise Mimetic) for metabolic. SLU-PP-332 (Exercise Mimetic) has more indexed studies (34). See the goal-by-goal breakdown above.

Is ARA 290 or SLU-PP-332 (Exercise Mimetic) better for weight loss?

SLU-PP-332 (Exercise Mimetic) shows the stronger metabolic & appetite profile (5.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is ARA 290 or SLU-PP-332 (Exercise Mimetic) better for muscle?

SLU-PP-332 (Exercise Mimetic) leads on the muscle & body-composition axis (4.0/5).

Which has more research, ARA 290 or SLU-PP-332 (Exercise Mimetic)?

ARA 290 has 33 approved studies indexed (Human evidence); SLU-PP-332 (Exercise Mimetic) has 34 (Human clinical). Higher counts mean more to read, not proven superiority.

Can you stack ARA 290 and SLU-PP-332 (Exercise Mimetic)?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of ARA 290 vs SLU-PP-332 (Exercise Mimetic)?

ARA 290: no community-reported effects logged yet. SLU-PP-332 (Exercise Mimetic): none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is ARA 290 or SLU-PP-332 (Exercise Mimetic) FDA-approved?

ARA 290 is a research-use compound and is not FDA-approved. SLU-PP-332 (Exercise Mimetic) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is SLU-PP-332 (Exercise Mimetic) better than ARA 290?

For metabolic, SLU-PP-332 (Exercise Mimetic) has the edge; for neuro, ARA 290 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

ARA 290 and SLU-PP-332 (Exercise Mimetic) are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.